No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial alzheimer disease

Genetic Epidemiology

Volumn 14, Issue 3, 1997, Pages 307-315

  Scott, W K ^a   Yamaoka, L H ^a   Locke, P A ^b   Rosi, B L ^a   Gaskell, P C ^a   Saunders, A M ^a   Conneally, P M ^c   Small, G W ^d   Farrer, L A ^e   Growdon, J H ^b   Roses, A D ^a   Pericak Vance, M A ^a   Haines, J L ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

APOE; Dementia; Genetics; Linkage analysis; PSEN1

Indexed keywords

BRAIN PROTEIN; DNA; PROTEIN PRECURSOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; ONSET AGE;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTRONS; LOD SCORE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PRESENILIN-1; REGRESSION ANALYSIS; SOFTWARE;

EID: 0030910513     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(1997)14:3<307::AID-GEPI8>3.0.CO;2-1     Document Type: Article

References (27)

1. Bassam BJ, Caetano-Anolles G, Gresshoff PM (1991): Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196:80-83.
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell P, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993): Apolipoprotein E4 gene dose and the risk of Alzheimer disease in late onset families. Science 261:921-923.
3. Davis S, Schroeder M, Goldin LR, Weeks DE (1996): Nonparametric simulation-based statistics for detecting linkage in general pedigrees. Am J Hum Genet 58:867-880.
4. Goate AM, Chartier-Harlin MC, Mullan MC, Brown J, Crawford F, Fidani L, Guiffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991): Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
5. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak-Vance MA (1996): No genetic effect of α 1-antichymotrypsin in Alzheimer disease. Genomics 33:53-56.
6. Higuchi S, Muramatsu T, Matsushita S, Arai H, Sasaki H (1996): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1186.
7. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995): APOE-4-associated Alzheimer's disease risk is modified by α 1-antichymotrypsin polymorphism. Nat Genet 10:486-488.
8. Kehoe P, Williams J, Lovestone S, Wilcock G, Owen MJ, Holmans P, Liddell M, Holmes C, Powall J, Neal J (1996): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1185.
9. Lathrop GM, Lalouel J-M, Julier C, Ott J (1984): Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443-3446.
10. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K., Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995): Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944.
12. Okuizumi K, Onodera O, Namba Y, Ikeda K, Yamamoto T, Seki K, Ueki A, Nanko S, Tanaka H, Takahashi H, Oyangi K, Mizusawa H, Kanazawa I, Tsuji S (1995): Genetic association of very low density lipoprotein (VLDL) receptor gene locus with sporadic Alzheimer's disease. Nat Genet 11:207-209.
13. Pérez-Tur J, Wavrant-De Vrieze F, Lambert JC, Chartier-Harlin MC, Alzheimer's Study Group (1996): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1560-1561.
14. Pericak-Vance MA, Haines JL (1995): Genetic susceptibility to Alzheimer's disease. Trends Gen 11:504-508.
15. Pericak-Vance MA, Bebout JL, Gaskell PC, Yamaoka LH, Hung W-Y, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA, Earl NL, Heyman A, Clark CM, Roses AD (1991): Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. Am J Hum Genet 48:1034-1050.
16. Pritchard ML, Saunders AM, Gaskell PC, Small GW, Conneally PM, Rosi B, Yamaoka LH, Roses AD, Haines JL, Pericak-Vance MA (1996): No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians. Neurosci Lett 209:105-108.
17. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Placentini S, Amaducci L, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St. George-Hyslop PH (1995): Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome I related to the Alzheimer's disease type 3 gene. Nature 376:775-778.
18. Roses AD, Devlin B, Conneally PM, Small GW, Saunders AM, Pritchard M, Locke PA, Haines JL, Pericak-Vance MA, Risch N (1995): Measuring the genetic contribution of APOE in late-onset Alzheimer disease (AD). Am J Hum Gen 57:A202.
19. Saunders AM, Strittmatter WJ, Schmechel D, St. George-Hyslop PH, Pericak-Vance MA, Joo SJ, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993): Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
20. Scott WK, Roses AD, Haines JL, Pericak-Vance MA (1996a): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1560.
21. Scott WK, Growdon JH, Roses AD, Haines JL, Pericak-Vance MA (1996b): Presenilin-1 polymorphism and Alzheimer's disease. Lancet 347:1186-1187.
22. Sherrington R, Rogaev E, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinski RJ, Wasco W, DaSilva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop PH (1995): Cloning of a novel gene bearing mis-sense mutations in early familial Alzheimer's disease. Nature 375:754-760.
23. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance MA, Enghild J, Salvesen GS, Roses AD (1993): Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90:1977-1981.
24. Thomson G (1994): Identifying complex disease genes: Progress and paradigms. Nat Genet 8:108-110.
25. Vance JM, Jonasson F, Lennon F, Sarrica J, Damji KF, Stauffer J, Pericak-Vance MA, and Klintworth GK (1996): Linkage of a gene for macular corneal dystrophy to chromosome 16. Am J Hum Genet 58:757-762.
26. van Duijn CM, deKnijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C (1994): Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 7:74-78.
27. Wragg M, Hutton M, Talbot C, and the Alzheimer's Disease Collaborative Group (1996): Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 347:509-512.